Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
Clinical trial NCT01753713 · COMPLETED
Trial details
- NCT number
- NCT01753713
- Sponsor
- Manmeet Ahluwalia, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-20
- Primary completion
- 2015-01-28
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.